Substantiation of the composition of a semi-solid dosage form with a probiotic component for use in dermatology

Keywords: skin microbiome, probiotics, dermatological diseases, semisolid dosage form, emulgel, gelling agents

Abstract

One of the important issues in the pharmaceutical development of a semisolid preparation for dermal use is the scientific and experimental justification for choosing the base-carrier of active substances.

The aim of this study was to experimentally substantiate the choice of rational combination of excipients in the development of a semisolid dosage form with a probiotic component for use in dermatology.

Materials and methods. Hydrophilic gelling agents were used as excipients in the study: Sepiplus 400, Aristoflex AVC, Carbopol 934, hydroxyethylcellulose HEC, sodium alginate. Physical and chemical, pharmaco-technological and microbiological methods were used to select the optimal basis. Colloidal stability was determined using a laboratory centrifuge at a speed of 6000 rpm for 5 min, an electronic thermometer and a water bath laboratory. Thermostability was determined in the thermostat at (40±2) °C for 24 hours. Investigation of the rheological properties of the samples was performed using a Rheolab QC (Anton Paar, Austria) rheoviscometer using a system of coaxial cylinders C-CC27/SS. The kinetics of water absorption of the samples were studied by dialysis through a semipermeable Cuprophan membrane, Type 150 pm at a temperature of (34±2) °C. The number of viable lactobacilli cells was determined by surface seeding on Petri dishes with dense MRS medium.

Research results. The results of the study of the number of viable lactobacilli cells showed that the lowest number of viable cells was in sample based on HEC. Tests for thermostability and colloidal stability showed that for sample No. 5 based on sodium alginate, stratification was observed in the experiment, which indicates its instability. These samples were excluded. Samples on Sepiplus 400 and Aristoflex AVC on a set of rheological features have advantages both consumer and technological; and sample on t Aristoflex AVC has the best indicators of osmotic activity and the viability of cells in the dynamics for this study.

Conclusions. As a result of physical and chemical (organoleptic, colloidal and thermostability), pharmaco-technological (osmotic and structural and mechanical properties) and microbiological studies (number of viable lactobacilli cells) studies it was found that further work should be carried out with a sample based on gelling agent Aristoflex AVC, which has the most optimal performance in this development for a semisolid dosage form with a probiotic component for use in dermatology

Downloads

Download data is not yet available.

Author Biographies

Alina Soloviova, National university of pharmacy

Department of Biotechnology

Halyna Kukhtenko, National University of Pharmacy

Department of Cosmetology and Aromology

Olha Kaliuzhnaia, National University of Pharmacy

Department of Biotechnology

References

Byrd, A. L., Belkaid, Y., Segre, J. A. (2018). The human skin microbiome. Nature Reviews Microbiology, 16 (3), 143–155. doi: http://doi.org/10.1038/nrmicro.2017.157

Dréno, B., Araviiskaia, E., Berardesca, E., Gontijo, G., Sanchez Viera, M., Xiang, L. F. et. al. (2016). Microbiome in healthy skin, update for dermatologists. Journal of the European Academy of Dermatology and Venereology, 30 (12), 2038–2047. doi: http://doi.org/10.1111/jdv.13965

Tkachenko, N., Chagarovskyi, O., Dets, N., Sevastyanova, E., Lanzhenko, L. (2017). “Lving” and “probiotic” cosmetics: modern view and defenitions. Food Science and Technology, 11 (4). doi: http://doi.org/10.15673/fst.v11i4.735

Fuchs-Tarlovsky, V., Marquez-Barba, M. F., Sriram, K. (2016). Probiotics in dermatologic practice. Nutrition, 32 (3), 289–295. doi: http://doi.org/10.1016/j.nut.2015.09.001

Drissi, F., Raoult, D., Merhej, V. (2017). Metabolic role of lactobacilli in weight modification in humans and animals. Microbial Pathogenesis, 106, 182–194. doi: http://doi.org/10.1016/j.micpath.2016.03.006

Niemeyer – van der Kolk, T., van der Wall, H. E. C., Balmforth, C., Van Doorn, M. B. A., Rissmann, R. (2018). A systematic literature review of the human skin microbiome as biomarker for dermatological drug development. British Journal of Clinical Pharmacology, 84 (10), 2178–2193. doi: http://doi.org/10.1111/bcp.13662

Egert, M., Simmering, R., Riedel, C. (2017). The Association of the Skin Microbiota With Health, Immunity, and Disease. Clinical Pharmacology & Therapeutics, 102 (1), 62–69. doi: http://doi.org/10.1002/cpt.698

Tavaria, F. K. (2017). Topical use of probiotics: The natural balance. Porto Biomedical Journal, 2 (3), 69–70. doi: http://doi.org/10.1016/j.pbj.2017.02.003

Wallen-Russell, C., Wallen-Russell, S. (2017). Meta Analysis of Skin Microbiome: New Link between Skin Microbiota Diversity and Skin Health with Proposal to Use This as a Future Mechanism to Determine Whether Cosmetic Products Damage the Skin. Cosmetics, 4 (2), 14. doi: http://doi.org/10.3390/cosmetics4020014

Knackstedt, R., Knackstedt, T., Gatherwright, J. (2020). The role of topical probiotics in skin conditions: A systematic review of animal and human studies and implications for future therapies. Experimental Dermatology, 29 (1), 15–21. doi: http://doi.org/10.1111/exd.14032

Ege, M. J. (2017). The Hygiene Hypothesis in the Age of the Microbiome. Annals of the American Thoracic Society, 14 (Supplement_5), S348–S353. doi: http://doi.org/10.1513/annalsats.201702-139aw

Soloviova, A., Kaliuzhnaia, O., Strelnikov, L. (2020). Primary selection of the prebiotic components in the complex dermatological therapeutic and preventive medicine with probiotic. ScienceRise: Pharmaceutical Science, 2 (24), 33–39. doi: http://doi.org/10.15587/2519-4852.2020.201104

Maguire, M., Maguire, G. (2017). The role of microbiota, and probiotics and prebiotics in skin health. Archives of Dermatological Research, 309 (6), 411–421. doi: http://doi.org/10.1007/s00403-017-1750-3

Lee, G. R., Maarouf, M., Hendricks, A. J., Lee, D. E., Shi, V. Y. (2019). Topical probiotics: the unknowns behind their rising popularity. Dermatology Online Journal, 25 (5). doi: http://doi.org/10.5070/d3255044062

Pelekh, I. R., Bilous, S. B. (2018). Modern approaches to use emulators and conservatives in the composition of dermatological drugs. Pharmaceutical Review, 3, 52–57. doi: http://doi.org/10.11603/2312-0967.2018.3.9453

Derzhavna Farmakopeia Ukrainy. Vol. 2 (2021). Kharkiv: Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmatsevtychnyi tsentr yakosti likarskykh zasobiv», 424.

McLoughlin, I. J., Wright, E. M., Tagg, J. R., Jain, R., Hale, J. D. F. (2021). Skin Microbiome – The Next Frontier for Probiotic Intervention. Probiotics and Antimicrobial Proteins. doi: http://doi.org/10.1007/s12602-021-09824-1

Zuikina, S. S., Vyshnevska, L. I. (2020). The substantiation of the technology of the bigel hydrophilic faction for the complex therapy of mastopathy in the aspect of methodological approaches to drug creation. Social Pharmacy in Health Care, 6 (1), 31–39. doi: http://doi.org/10.24959/sphhcj.20.181

Soloviova, A. V., Kaliuzhnaia, O. S. (2021). Selection of auxiliary components for the development of a soft preparation for probyotic components. Fundamentalni ta prykladni doslidzhennia u halizi farmatsevtychnoi tekhnolohii. Kharkiv: NFaU, 28–31.

Akne. Klinichna nastanova, zasnovana na dokazakh (2017). Derzhavnyi ekspertnyi tsentr Ministerstva okhorony zdorovia Ukrainy, 101.


👁 114
⬇ 92
Published
2021-11-30
How to Cite
Soloviova, A., Kukhtenko, H., & Kaliuzhnaia, O. (2021). Substantiation of the composition of a semi-solid dosage form with a probiotic component for use in dermatology. EUREKA: Health Sciences, (6), 54-63. https://doi.org/10.21303/2504-5679.2021.002181
Section
Pharmacology, Toxicology and Pharmaceutical Science